Several inflammatory indicators have been shown to predict the prognosis of patients with glioma, including platelet-to-lymphocyte ratio (PLR), lymphocyte-to-monocyte ratio (LMR), neutrophil-to-lymphocyte ratio (NLR), and the albumin to globular albumin ratio (AGR) (4–6). This evidence concerns the gene ALB and central nervous system cancer.